ARTICLE | Clinical News
AC-1204: Ph III NOURISH AD data
March 10, 2017 12:35 AM UTC
Top-line data from the double-blind, U.S. Phase III NOURISH AD trial in about 418 non-carriers of apolipoprotein E (APOE) epsilon 4 (APOE4) with mild to moderate AD showed that once-daily 40 g oral AC...
BCIQ Company Profiles